Hollencrest Capital Management Adicet Bio, Inc. Call Options Transaction History
Hollencrest Capital Management
- $2.27 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACET
# of Institutions
54Shares Held
53.1MCall Options Held
27.2KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA11.4MShares$8.93 Million0.25% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$6.41 Million0.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$5.88 Million0.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$2.93 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$2.55 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $31.2M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...